Hubei Jumpcan Pharmaceutical Co., Ltd. Stock: price and insider trades · China
济川药业
Hubei Jumpcan Pharmaceutical Co., Ltd.: what insiders have been doing
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). In the past year (22 October 2025 to 22 October 2026), 2 filings came from 2 insiders.
Only sales appear on the open market, 2 sales in all totalling €626k, filed by 2 insiders. At €316k, the sale published on 31 August 2026 by 黄曲荣 is the largest of the period.
Across the 511 companies tracked on its exchange, the median is 2 filings; at 2 filings, this issuer sits right on that mark. The full history, which starts in 2026, counts no purchases against 2 sales.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Hubei Jumpcan Pharmaceutical Co., Ltd.
Jichuan Pharmaceutical is a company specializing in the manufacturing of pharmaceutical products in China. It is listed on the Shanghai Stock Exchange.
